Thematic Investing

VanEck Vectors^® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS^® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

Fund Ticker
BBH
Exchange
NASDAQ
ETF Structure
Physical
Administrator
Van Eck Associates
Custodian
State Street Bank and Trust Company
Index Ticker
MVBBHTR
Index Rebalancing
Quarterly

as of 05/05/21

30-Day SEC Yield¹
0.13%
Total Net Assets
$506.4M
Number of Holdings
25
Options
Available
Gross Expense Ratio²
0.39%
Net Expense Ratio/TER²
0.35%
Distribution Frequency
Annual

Schedule a Call

Key Points

Highly Liquid Companies
Index seeks to track the most liquid companies in the industry based on market cap and trading volume

Industry Leaders
Index methodology favors the largest companies in the industry

Global Scope
Portfolio may include both domestic and U.S. listed foreign companies allowing for enhanced industry representation

Trading Information

Fund Ticker
BBH
Index Total Return Ticker
MVBBHTR
NAV
BBHNV
Intraday NAV (IIV)⁴
BBHIV
Shares Outstanding
2,821,503
Estimated Cash
BBHEU
Total Cash
BBHTC
CUSIP
92189F726
ISIN
US92189F7261

Source: Bloomberg

Fees and Expenses²

Management Fee
0.35%
Other Expenses
0.04%
Gross Expense Ratio
0.39%
Fee Waivers and
Expense Reimbursement
-0.04%
Net Expense Ratio/TER²
0.35%

²Expenses for BBH are capped contractually at 0.35% until February 1, 2022. Cap excludes acquired fund fees and expenses, interest expense, trading expenses, taxes and extraordinary expenses.

Investment Professionals

Peter Liao, CFA

Portfolio Manager and Head of Equity ETFs
Oversees the Equity ETF Investment Management Team including development and management of index replication and optimization strategies
Joined VanEck in 2005
CFA charterholder; member of the CFA Society New York
BA, Mathematics and Economics, New York University

Guo Hua (Jason) Jin

Portfolio Manager and Analyst for Equity ETFs
Joined VanEck in 2007
Prior to his current role, held a portfolio administration position at VanEck
Previously, Portfolio Analyst at Evaluation Associates
BS, Business Administration (concentration in Financial Analysis), State University of New York at Buffalo

Griffin Driscoll

Analyst for Equity ETFs
Joined VanEck in 2018
Prior to joining VanEck, ETF Basket Operations Analyst at JPMorgan
BS, Finance, Providence College

Ralph Lasta

Analyst for Equity ETFs
Joined VanEck in 2019
Prior to VanEck, Intermediate Representative, Exchange Traded Funds at BNY Mellon.
BS, Accounting, Hunter College

Prices as of 05/05/21

	NAV/ Market Price	Volume 30-Day Avg./ Last Trading Day	Daily Change NAV/ Last Price	YTD Change NAV/ Last Price	Premium/ Discount	Prem/Discount Distribution Charts	NAV & Prem/Discount History	30-Day Median Bid Ask Spread	NAV Chart
BBH	$179.48 $179.28	9,990 17,473	-$2.08 / -1.15% $-1.84 / -1.02%	+5.77% +5.65%	$-0.20 -0.11%			0.09%

Premium/Discount History as of 05/05/21

		Calendar Year 2020	2Q 2020	3Q 2020	4Q 2020	1Q 2021
	Days closed at a premium	145	38	49	27	33
BBH	Days closed at NAV	9	1	1	3	0
	Days closed at a discount	99	24	14	34	28

Performance History: Average Annual Total Returns* (%)
View All ETFs View All Indices

Month End as of 03/31/21
Quarter End as of 03/31/21

	1 MO	3 MO	YTD	1 YR	3 YR	5 YR	10 YR	LIFE 12/20/11
BBH (NAV)	-2.00	3.25	3.25	37.48	13.81	11.50	--	19.19
BBH (Share Price)	-1.99	3.39	3.39	37.55	13.84	11.55	--	19.22
MVBBHTR (Index)	-1.98	3.29	3.29	37.64	14.00	11.68	--	19.39
Performance Differential (NAV - Index)	-0.02	-0.04	-0.04	-0.16	-0.19	-0.18	--	-0.20

	1 MO	3 MO	YTD	1 YR	3 YR	5 YR	10 YR	LIFE 12/20/11
BBH (NAV)	-2.00	3.25	3.25	37.48	13.81	11.50	--	19.19
BBH (Share Price)	-1.99	3.39	3.39	37.55	13.84	11.55	--	19.22
MVBBHTR (Index)	-1.98	3.29	3.29	37.64	14.00	11.68	--	19.39
Performance Differential (NAV - Index)	-0.02	-0.04	-0.04	-0.16	-0.19	-0.18	--	-0.20

*Returns less than one year are not annualized.

The table presents past performance which is no guarantee of future results and which may be lower or higher than current performance. Returns reflect temporary contractual fee waivers and/or expense reimbursements. Had the ETF incurred all expenses and fees, investment returns would have been reduced. Investment returns and ETF share values will fluctuate so that investors' shares, when redeemed, may be worth more or less than their original cost. ETF returns assume that dividends and capital gains distributions have been reinvested in the Fund at NAV.

Top 10 Holdings (%) as of 03/31/21 Daily Holdings

Total Holdings: 25

Swipe
to view
full data

	Holding Name	Ticker	Shares	Market Value (US$)	% of Net Assets
	AMGEN INC	AMGN US	200,515	49,890,137	10.09
	GILEAD SCIENCES INC	GILD US	399,901	25,845,602	5.23
	BIOGEN INC	BIIB US	90,968	25,448,298	5.15
	IQVIA HOLDINGS INC	IQV US	125,906	24,317,485	4.92
	MODERNA INC	MRNA US	184,665	24,181,882	4.89
	REGENERON PHARMACEUTICALS INC	REGN US	51,052	24,154,743	4.89
	VERTEX PHARMACEUTICALS INC	VRTX US	111,481	23,956,152	4.85
	ALEXION PHARMACEUTICALS INC	ALXN US	155,652	23,800,747	4.81
	ILLUMINA INC	ILMN US	59,805	22,968,708	4.65
	GUARDANT HEALTH INC	GH US	148,301	22,638,148	4.58
Top 10 Total (%)					54.06

These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 03/31/21

Country
% of Net Assets
■
United States
90.38
■
China
4.29
■
Germany
2.91
■
Switzerland
2.45
■
Other/Cash
-0.03

Sector Weightings (%) as of 03/31/21

Sector
% of Net Assets
■
Health Care
100.0
■
Other/Cash
0.0

Thematic Investing

CEO's Investment Outlook

Related Funds

BBHVanEck Vectors Biotech ETF

Fund Description